




Searching News Database: Biocartis
HSMN NewsFeed - 26 Mar 2020
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
HSMN NewsFeed - 28 Oct 2014
Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund
Advent Life Sciences Raises £145.5M (USD 235M) for its Second Life Sciences Venture Capital Fund